EP2970191
Pýrídínafleiður eins og þeim er endurraðað við genaleiðslu (RET) kínasahemla
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2014EP published:
21.12.2016EP application number:
14713598.2
EP translation filed:
22.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2018
Title:
PYRIDINE DERIVATIVES AS REARRANGED DURING TRANSFECTION (RET) KINASE INHIBITORS
Timeline
Today
14.3.2014EP application
21.12.2016EP Publication
22.2.2017Translation submitted
15.3.2017Registration published
13.3.2018Expires
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
980 Great West Road, BrentfordMiddlesex TW8 9GS, GB
Inventor
Name:
EIDAM, Hilary SchenckAddress:
King of Prussia, Pennsylvania, US
Name:
DEMARTINO, Michael P.Address:
Collegeville, Pennsylvania, US
Name:
GONG, ZhenAddress:
Shanghai, CN
Name:
GUAN, Amy HuipingAddress:
Shanghai, CN
Name:
RAHA, KaushikAddress:
Collegeville, Pennsylvania, US
Name:
WU, ChengdeAddress:
Shanghai,, CN
Name:
YANG, HaiyingAddress:
Shanghai,, CN
Name:
YU, HaiyuAddress:
Shanghai,, CN
Name:
ZHANG, ZhiliuAddress:
Shanghai, CN
Name:
CHEUNG, MuiAddress:
King of Prussia, PA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2013/072683Date:
15.3.2013Country:
WO
Number:
PCT/CN2013/090059Date:
20.12.2013Country:
WO
Number:
PCT/CN2014/072449Date:
24.2.2014Country:
WO
Classification
Categories:
C07D 401/12, C07D 413/12, C07D 213/69, A61K 31/4412, A61P 1/06
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 1.2.2017
Expires: 13.3.2018
Payer: Örn Þór, slf.